CS logo
small CS logo
Kindai University Hospital

Osaka, Japan
University hospital in Osakasayama
377-2 Onohigashi, Osakasayama, Osaka 589-8511

About Kindai University Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Kindai University Hospital


During the past decade, Kindai University Hospital conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 19 clinical trials were completed, i.e. on average, 40.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 10 clinical trials were completed. i.e. 43.5% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kindai University Hospital" #1 sponsor was "Hoffmann-La Roche" with 25 trials, followed by "Pfizer" with 8 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Daiichi Sankyo Co., Ltd." with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 29 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kindai University Hospital" #1 collaborator was "AstraZeneca" with 4 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator, "Human Genome Center, Institute of Medical Science, University of Tokyo" with 2 trials as a collaborator and "Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

Clinical Trials Conditions at Kindai University Hospital


According to Clinical.Site data, the most researched conditions in "Kindai University Hospital" are "Carcinoma, Renal Cell" (5 trials), "Non-Small Cell Lung Cancer" (4 trials), "Carcinoma, Hepatocellular" (3 trials), "Hepatocellular Carcinoma" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Kindai University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Kindai University Hospital


Most popular intervention types in "Kindai University Hospital" are "Drug" (63 trials), "Biological" (5 trials), "Procedure" (4 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (13 trials), "Placebo" (10 trials), "Cisplatin" (6 trials), "Carboplatin" (5 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Kindai University Hospital


The vast majority of trials in "Kindai University Hospital" are 72 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Kindai University Hospital


Currently, there are NaN active trials in "Kindai University Hospital". undefined are not yet recruiting, 13 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Kindai University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Kindai University Hospital, 9 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".